The diagnostic accuracy of the faecal immunochemical test for the detection of early-onset colorectal cancer: an age-stratified analysis in South West England.

IF 6.8 1区 医学 Q1 ONCOLOGY
Melissa Barlow, David Messenger, Ryan Preece, Amy Prowse, Gary Abel, Willie Hamilton, Samuel Wd Merriel, Adam Chambers, Sarah Er Bailey
{"title":"The diagnostic accuracy of the faecal immunochemical test for the detection of early-onset colorectal cancer: an age-stratified analysis in South West England.","authors":"Melissa Barlow, David Messenger, Ryan Preece, Amy Prowse, Gary Abel, Willie Hamilton, Samuel Wd Merriel, Adam Chambers, Sarah Er Bailey","doi":"10.1038/s41416-025-03154-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The incidence of early-onset colorectal cancer (EOCRC) is rising rapidly, with diagnoses typically occurring at a more advanced stage than late-onset CRC. In the absence of screening for younger patients, diagnosis relies on symptomatic presentation. The faecal immunochemical test (FIT) is a diagnostic triage tool for patients presenting with clinical features of CRC in primary care, though its performance in individuals under 50 years is not well established.</p><p><strong>Methods: </strong>A cohort of 38,117 symptomatic patients aged 18-49 years in upper South West England underwent FIT in primary care between 01/01/2021 and 10/07/2023. A FIT result of ≥10 µg Hb/g faeces was considered positive. In the same region, 528 EOCRC diagnoses were recorded between 01/01/2021 and 10/10/2024.</p><p><strong>Results: </strong>Of the 528 EOCRC patients, 105 (20%) underwent FIT in the year before diagnosis. The sensitivity of FIT was 92.4% (95% CI 85.5-96.7%), specificity was 88.5% (88.2-88.8%), positive predictive value (PPV) was 2.2% (1.8-2.6%), and negative predictive value was 100% (100-100%). PPVs decreased in younger age groups (18-29, 30-39, 40-49 years).</p><p><strong>Conclusions: </strong>FIT performs excellently for patients aged 40-49; however, it may not be used optimally in patients <40 years. A more targeted strategy is needed to guide investigation in younger patients.</p>","PeriodicalId":9243,"journal":{"name":"British Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41416-025-03154-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The incidence of early-onset colorectal cancer (EOCRC) is rising rapidly, with diagnoses typically occurring at a more advanced stage than late-onset CRC. In the absence of screening for younger patients, diagnosis relies on symptomatic presentation. The faecal immunochemical test (FIT) is a diagnostic triage tool for patients presenting with clinical features of CRC in primary care, though its performance in individuals under 50 years is not well established.

Methods: A cohort of 38,117 symptomatic patients aged 18-49 years in upper South West England underwent FIT in primary care between 01/01/2021 and 10/07/2023. A FIT result of ≥10 µg Hb/g faeces was considered positive. In the same region, 528 EOCRC diagnoses were recorded between 01/01/2021 and 10/10/2024.

Results: Of the 528 EOCRC patients, 105 (20%) underwent FIT in the year before diagnosis. The sensitivity of FIT was 92.4% (95% CI 85.5-96.7%), specificity was 88.5% (88.2-88.8%), positive predictive value (PPV) was 2.2% (1.8-2.6%), and negative predictive value was 100% (100-100%). PPVs decreased in younger age groups (18-29, 30-39, 40-49 years).

Conclusions: FIT performs excellently for patients aged 40-49; however, it may not be used optimally in patients <40 years. A more targeted strategy is needed to guide investigation in younger patients.

粪便免疫化学检测早发性结直肠癌的诊断准确性:英格兰西南部的年龄分层分析。
背景:早发性结直肠癌(EOCRC)的发病率正在迅速上升,其诊断通常发生在比晚发性结直肠癌更晚期的阶段。由于缺乏对年轻患者的筛查,诊断依赖于症状表现。粪便免疫化学试验(FIT)是初级保健中具有CRC临床特征的患者的诊断分类工具,尽管其在50岁以下个体中的表现尚未得到很好的确定。方法:在2021年1月1日至2023年10月7日期间,英格兰西南北部38,117名年龄在18-49岁的有症状患者在初级保健中接受了FIT。FIT结果≥10µg Hb/g粪便被认为是阳性。在同一地区,在2021年1月1日至2024年10月10日期间记录了528例EOCRC诊断。结果:528例EOCRC患者中,105例(20%)在诊断前一年接受了FIT。FIT的敏感性为92.4% (95% CI 85.5-96.7%),特异性为88.5%(88.2-88.8%),阳性预测值(PPV)为2.2%(1.8-2.6%),阴性预测值为100%(100-100%)。较年轻年龄组(18-29岁、30-39岁、40-49岁)PPVs下降。结论:适合40 ~ 49岁患者;然而,它可能不适合患者使用
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
British Journal of Cancer
British Journal of Cancer 医学-肿瘤学
CiteScore
15.10
自引率
1.10%
发文量
383
审稿时长
6 months
期刊介绍: The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research.It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信